Gabales, King Mark N.
HRN: 21-71-49 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2022
CEFUROXIME 750MG (VIAL)
07/21/2022
07/28/2022
IV
400 Mg
Q8hrs
PCAP C
Waiting Final Action